Retinopathy of prematurity - A giant in the developing world

Indian Pediatrics

Volumn 46, Issue 3, 2009, Pages 211-212

  Azad, Rajvardhan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASTIGMATISM; COST BENEFIT ANALYSIS; EDITORIAL; HEALTH CARE; HUMAN; MEDICAL SPECIALIST; MYOPIA; OXYGEN THERAPY; PRACTICE GUIDELINE; RETROLENTAL FIBROPLASIA; RISK FACTOR; SCREENING; SURVIVAL RATE; VISUAL ACUITY;

DEVELOPING COUNTRIES; DISEASE PROGRESSION; HUMANS; INDIA; INFANT, NEWBORN; NEONATAL SCREENING; OXYGEN INHALATION THERAPY; PUBLIC HEALTH; RETINOPATHY OF PREMATURITY; RISK FACTORS; WORLD HEALTH;

EID: 62949228359     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Kamholz KL, Cole CH, Gray JE, Zupancic JA Cost-effectiveness of early treatment for retinopathy of prematurity. Pediatrics 2009; 123: 262-269.
2. Vinekar A, Dogra MR, Sangtam T, Narang A, Gupta A. Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: ten year data from a tertiary care center in a developing country. Indian J Ophthalmol 2007; 55: 331-336.
3. Azad RV, Chandra P, Patwardhan S, Gupta A Importance of "Third Criteria" for ROP screening in developing countries. J Ped Opth Strabismus (inress).
4. Azad RV, Manjunatha NP, Pal N, Deorari AK Retinopathy of prematurity screening by non-retinologists. Indian J Pediatr 2006; 73: 515-518.
5. Quinn GE, Dobson V, Davitt BV, Hardy RJ, Tung B, Pedroza C, et al. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age Ophthalmology 2008; 115: 1058-1064.